Qiu W - Search Results

1

Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma.

Jiang J, Cai Z, Zheng R, Yuan Y, Lv X, Qiu W. Jiang J, et al. Among authors: qiu w. Eur Arch Otorhinolaryngol. 2024 Apr 26. doi: 10.1007/s00405-024-08572-6. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38671169

2

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.

Liang H, Xiang YQ, Lv X, Xie CQ, Cao SM, Wang L, Qian CN, Yang J, Ye YF, Gan F, Ke LR, Yu YH, Liu GY, Qiu WZ, Huang XJ, Wen CH, You N, Wang XQ, Guo X, Xia WX. Liang H, et al. Eur J Cancer. 2017 Mar;73:48-60. doi: 10.1016/j.ejca.2016.12.009. Epub 2017 Feb 3. Eur J Cancer. 2017. PMID: 28161498

3

Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.

Ke LR, Xia WX, Qiu WZ, Huang XJ, Yang J, Yu YH, Liang H, Liu GY, Ye YF, Xiang YQ, Guo X, Lv X. Ke LR, et al. BMC Cancer. 2017 Feb 15;17(1):134. doi: 10.1186/s12885-017-3080-4. BMC Cancer. 2017. PMID: 28202000 Free PMC article. Clinical Trial.

4

Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis.

Xia WX, Liang H, Lv X, Wang L, Qian CN, Ye YF, Ke LR, Qiu WZ, Yu YH, Huang XJ, Liu GY, Zhao C, Xiang YQ, Guo X. Xia WX, et al. Oral Oncol. 2017 Apr;67:167-174. doi: 10.1016/j.oraloncology.2017.02.026. Epub 2017 Mar 2. Oral Oncol. 2017. PMID: 28351572

5

A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.

Ke LR, Xia WX, Qiu WZ, Huang XJ, Yu YH, Liang H, Liu GY, Xiang YQ, Guo X, Lv X. Ke LR, et al. Oral Oncol. 2017 Jul;70:7-13. doi: 10.1016/j.oraloncology.2017.04.018. Epub 2017 May 9. Oral Oncol. 2017. PMID: 28622892 Clinical Trial.

6

A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.

Qiu WZ, Ke LR, Xia WX, Yang J, Yu YH, Liang H, Huang XJ, Liu GY, Li WZ, Xiang YQ, Guo X, Lv X. Qiu WZ, et al. PLoS One. 2017 Aug 10;12(8):e0182963. doi: 10.1371/journal.pone.0182963. eCollection 2017. PLoS One. 2017. PMID: 28797119 Free PMC article.

7

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.

Qiu WZ, Zhang HB, Xia WX, Ke LR, Yang J, Yu YH, Liang H, Huang XJ, Liu GY, Li WZ, Xiang YQ, Kang TB, Guo X, Lv X. Qiu WZ, et al. J Exp Clin Cancer Res. 2018 Apr 17;37(1):85. doi: 10.1186/s13046-018-0722-6. J Exp Clin Cancer Res. 2018. PMID: 29665837 Free PMC article.

8

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.

Liu GY, Lv X, Wu YS, Mao MJ, Ye YF, Yu YH, Liang H, Yang J, Ke LR, Qiu WZ, Huang XJ, Li WZ, Guo X, Xiang YQ, Xia WX. Liu GY, et al. Cancer Commun (Lond). 2018 May 10;38(1):21. doi: 10.1186/s40880-018-0283-2. Cancer Commun (Lond). 2018. PMID: 29764487 Free PMC article.

9

The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma.

Yu Y, Ke L, Lv X, Ling YH, Lu J, Liang H, Qiu W, Huang X, Liu G, Li W, Guo X, Xia W, Xiang Y. Yu Y, et al. Among authors: qiu w. Cancer Manag Res. 2018 Jul 9;10:1935-1946. doi: 10.2147/CMAR.S167071. eCollection 2018. Cancer Manag Res. 2018. PMID: 30022852 Free PMC article.

10

The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area.

Liang H, Lv X, Wang L, Wu YS, Sun R, Ye YF, Ke LR, Yang Q, Yu YH, Qiu WZ, Liu GY, Huang XJ, Li WZ, Lv SH, Guo X, Xiang YQ, Xia WX. Liang H, et al. Ther Adv Med Oncol. 2018 Jul 20;10:1758835918782331. doi: 10.1177/1758835918782331. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30046357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,162 results

Search Page